English
简体中文
Total: £ 56.28
Published Date: 2024-12-04 | Pages: 107 | Tables: 184 | Medical Care
The global market for Computer-aided Detection (CAD) for Breast Cancer Screening was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
North American market for Computer-aided Detection (CAD) for Breast Cancer Screening was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Computer-aided Detection (CAD) for Breast Cancer Screening was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for Computer-aided Detection (CAD) for Breast Cancer Screening was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of Computer-aided Detection (CAD) for Breast Cancer Screening include CureMetrix, Inc., FUJIFILM Corporation, GE Healthcare, Hitachi, Ltd., Hologic, Inc., iCAD Inc., IMS Giotto SpA, Konica Minolta and McKesson Corporation, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Computer-aided Detection (CAD) for Breast Cancer Screening, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Computer-aided Detection (CAD) for Breast Cancer Screening by region & country, by Type, and by Application.
The Computer-aided Detection (CAD) for Breast Cancer Screening market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Computer-aided Detection (CAD) for Breast Cancer Screening.
Market Segmentation
By Company
CureMetrix, Inc.
FUJIFILM Corporation
GE Healthcare
Hitachi, Ltd.
Hologic, Inc.
iCAD Inc.
IMS Giotto SpA
Konica Minolta
McKesson Corporation
Merge Healthcare (IBM Corporation)
Neusoft Corporation
Qlarity Imaging, LLC
Siemens Healthineers AG
Segment by Type:
Mammography CAD
MRI CAD
PET/CT CAD
Ultrasound CAD
Segment by Application
Clinics
Hospital
Medical Examination Center
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Computer-aided Detection (CAD) for Breast Cancer Screening manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Computer-aided Detection (CAD) for Breast Cancer Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Computer-aided Detection (CAD) for Breast Cancer Screening in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Computer-aided Detection (CAD) for Breast Cancer Screening Product Introduction
1.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Market Size Forecast
1.3 Computer-aided Detection (CAD) for Breast Cancer Screening Market Trends & Drivers
1.3.1 Computer-aided Detection (CAD) for Breast Cancer Screening Industry Trends
1.3.2 Computer-aided Detection (CAD) for Breast Cancer Screening Market Drivers & Opportunity
1.3.3 Computer-aided Detection (CAD) for Breast Cancer Screening Market Challenges
1.3.4 Computer-aided Detection (CAD) for Breast Cancer Screening Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Players Revenue Ranking (2023)
2.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Revenue by Company (2019-2024)
2.3 Key Companies Computer-aided Detection (CAD) for Breast Cancer Screening Manufacturing Base Distribution and Headquarters
2.4 Key Companies Computer-aided Detection (CAD) for Breast Cancer Screening Product Offered
2.5 Key Companies Time to Begin Mass Production of Computer-aided Detection (CAD) for Breast Cancer Screening
2.6 Computer-aided Detection (CAD) for Breast Cancer Screening Market Competitive Analysis
2.6.1 Computer-aided Detection (CAD) for Breast Cancer Screening Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Computer-aided Detection (CAD) for Breast Cancer Screening Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Mammography CAD
3.1.2 MRI CAD
3.1.3 PET/CT CAD
3.1.4 Ultrasound CAD
3.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type
3.2.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, by Type (2019-2030)
3.2.3 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Clinics
4.1.2 Hospital
4.1.3 Medical Examination Center
4.1.4 Others
4.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application
4.2.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, by Application (2019-2030)
4.2.3 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region
5.1.1 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (2019-2024)
5.1.3 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (2025-2030)
5.1.4 Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
5.2.2 North America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
5.3.2 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
5.4.2 Asia Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
5.5.2 South America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
5.6.2 Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value
6.3 United States
6.3.1 United States Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
6.3.2 United States Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
6.4.2 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
6.5.2 China Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
6.5.3 China Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
6.6.2 Japan Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
6.7.2 South Korea Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
6.8.2 Southeast Asia Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019-2030
6.9.2 India Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
6.9.3 India Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 CureMetrix, Inc.
7.1.1 CureMetrix, Inc. Profile
7.1.2 CureMetrix, Inc. Main Business
7.1.3 CureMetrix, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.1.4 CureMetrix, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.1.5 CureMetrix, Inc. Recent Developments
7.2 FUJIFILM Corporation
7.2.1 FUJIFILM Corporation Profile
7.2.2 FUJIFILM Corporation Main Business
7.2.3 FUJIFILM Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.2.4 FUJIFILM Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.2.5 FUJIFILM Corporation Recent Developments
7.3 GE Healthcare
7.3.1 GE Healthcare Profile
7.3.2 GE Healthcare Main Business
7.3.3 GE Healthcare Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.3.4 GE Healthcare Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.3.5 Hitachi, Ltd. Recent Developments
7.4 Hitachi, Ltd.
7.4.1 Hitachi, Ltd. Profile
7.4.2 Hitachi, Ltd. Main Business
7.4.3 Hitachi, Ltd. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.4.4 Hitachi, Ltd. Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.4.5 Hitachi, Ltd. Recent Developments
7.5 Hologic, Inc.
7.5.1 Hologic, Inc. Profile
7.5.2 Hologic, Inc. Main Business
7.5.3 Hologic, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.5.4 Hologic, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.5.5 Hologic, Inc. Recent Developments
7.6 iCAD Inc.
7.6.1 iCAD Inc. Profile
7.6.2 iCAD Inc. Main Business
7.6.3 iCAD Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.6.4 iCAD Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.6.5 iCAD Inc. Recent Developments
7.7 IMS Giotto SpA
7.7.1 IMS Giotto SpA Profile
7.7.2 IMS Giotto SpA Main Business
7.7.3 IMS Giotto SpA Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.7.4 IMS Giotto SpA Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.7.5 IMS Giotto SpA Recent Developments
7.8 Konica Minolta
7.8.1 Konica Minolta Profile
7.8.2 Konica Minolta Main Business
7.8.3 Konica Minolta Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.8.4 Konica Minolta Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.8.5 Konica Minolta Recent Developments
7.9 McKesson Corporation
7.9.1 McKesson Corporation Profile
7.9.2 McKesson Corporation Main Business
7.9.3 McKesson Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.9.4 McKesson Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.9.5 McKesson Corporation Recent Developments
7.10 Merge Healthcare (IBM Corporation)
7.10.1 Merge Healthcare (IBM Corporation) Profile
7.10.2 Merge Healthcare (IBM Corporation) Main Business
7.10.3 Merge Healthcare (IBM Corporation) Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.10.4 Merge Healthcare (IBM Corporation) Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.10.5 Merge Healthcare (IBM Corporation) Recent Developments
7.11 Neusoft Corporation
7.11.1 Neusoft Corporation Profile
7.11.2 Neusoft Corporation Main Business
7.11.3 Neusoft Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.11.4 Neusoft Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.11.5 Neusoft Corporation Recent Developments
7.12 Qlarity Imaging, LLC
7.12.1 Qlarity Imaging, LLC Profile
7.12.2 Qlarity Imaging, LLC Main Business
7.12.3 Qlarity Imaging, LLC Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.12.4 Qlarity Imaging, LLC Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.12.5 Qlarity Imaging, LLC Recent Developments
7.13 Siemens Healthineers AG
7.13.1 Siemens Healthineers AG Profile
7.13.2 Siemens Healthineers AG Main Business
7.13.3 Siemens Healthineers AG Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
7.13.4 Siemens Healthineers AG Computer-aided Detection (CAD) for Breast Cancer Screening Revenue (US$ Million) & (2019-2024)
7.13.5 Siemens Healthineers AG Recent Developments
8 Industry Chain Analysis
8.1 Computer-aided Detection (CAD) for Breast Cancer Screening Industrial Chain
8.2 Computer-aided Detection (CAD) for Breast Cancer Screening Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Computer-aided Detection (CAD) for Breast Cancer Screening Sales Model
8.5.2 Sales Channel
8.5.3 Computer-aided Detection (CAD) for Breast Cancer Screening Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Computer-aided Detection (CAD) for Breast Cancer Screening Market Trends
Table 2. Computer-aided Detection (CAD) for Breast Cancer Screening Market Drivers & Opportunity
Table 3. Computer-aided Detection (CAD) for Breast Cancer Screening Market Challenges
Table 4. Computer-aided Detection (CAD) for Breast Cancer Screening Market Restraints
Table 5. Global Computer-aided Detection (CAD) for Breast Cancer Screening Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Computer-aided Detection (CAD) for Breast Cancer Screening Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Computer-aided Detection (CAD) for Breast Cancer Screening Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Computer-aided Detection (CAD) for Breast Cancer Screening Product Type
Table 9. Key Companies Time to Begin Mass Production of Computer-aided Detection (CAD) for Breast Cancer Screening
Table 10. Global Computer-aided Detection (CAD) for Breast Cancer Screening Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Computer-aided Detection (CAD) for Breast Cancer Screening as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (2019-2024) & (%)
Table 27. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2025-2030) & (US$ Million)
Table 31. CureMetrix, Inc. Basic Information List
Table 32. CureMetrix, Inc. Description and Business Overview
Table 33. CureMetrix, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
Table 34. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of CureMetrix, Inc. (2019-2024)
Table 35. CureMetrix, Inc. Recent Developments
Table 36. FUJIFILM Corporation Basic Information List
Table 37. FUJIFILM Corporation Description and Business Overview
Table 38. FUJIFILM Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
Table 39. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of FUJIFILM Corporation (2019-2024)
Table 40. FUJIFILM Corporation Recent Developments
Table 41. GE Healthcare Basic Information List
Table 42. GE Healthcare Description and Business Overview
Table 43. GE Healthcare Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
Table 44. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of GE Healthcare (2019-2024)
Table 45. GE Healthcare Recent Developments
Table 46. Hitachi, Ltd. Basic Information List
Table 47. Hitachi, Ltd. Description and Business Overview
Table 48. Hitachi, Ltd. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
Table 49. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of Hitachi, Ltd. (2019-2024)
Table 50. Hitachi, Ltd. Recent Developments
Table 51. Hologic, Inc. Basic Information List
Table 52. Hologic, Inc. Description and Business Overview
Table 53. Hologic, Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
Table 54. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of Hologic, Inc. (2019-2024)
Table 55. Hologic, Inc. Recent Developments
Table 56. iCAD Inc. Basic Information List
Table 57. iCAD Inc. Description and Business Overview
Table 58. iCAD Inc. Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
Table 59. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of iCAD Inc. (2019-2024)
Table 60. iCAD Inc. Recent Developments
Table 61. IMS Giotto SpA Basic Information List
Table 62. IMS Giotto SpA Description and Business Overview
Table 63. IMS Giotto SpA Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
Table 64. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of IMS Giotto SpA (2019-2024)
Table 65. IMS Giotto SpA Recent Developments
Table 66. Konica Minolta Basic Information List
Table 67. Konica Minolta Description and Business Overview
Table 68. Konica Minolta Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
Table 69. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of Konica Minolta (2019-2024)
Table 70. Konica Minolta Recent Developments
Table 71. McKesson Corporation Basic Information List
Table 72. McKesson Corporation Description and Business Overview
Table 73. McKesson Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
Table 74. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of McKesson Corporation (2019-2024)
Table 75. McKesson Corporation Recent Developments
Table 76. Merge Healthcare (IBM Corporation) Basic Information List
Table 77. Merge Healthcare (IBM Corporation) Description and Business Overview
Table 78. Merge Healthcare (IBM Corporation) Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
Table 79. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of Merge Healthcare (IBM Corporation) (2019-2024)
Table 80. Merge Healthcare (IBM Corporation) Recent Developments
Table 81. Neusoft Corporation Basic Information List
Table 82. Neusoft Corporation Description and Business Overview
Table 83. Neusoft Corporation Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
Table 84. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of Neusoft Corporation (2019-2024)
Table 85. Neusoft Corporation Recent Developments
Table 86. Qlarity Imaging, LLC Basic Information List
Table 87. Qlarity Imaging, LLC Description and Business Overview
Table 88. Qlarity Imaging, LLC Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
Table 89. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of Qlarity Imaging, LLC (2019-2024)
Table 90. Qlarity Imaging, LLC Recent Developments
Table 91. Siemens Healthineers AG Basic Information List
Table 92. Siemens Healthineers AG Description and Business Overview
Table 93. Siemens Healthineers AG Computer-aided Detection (CAD) for Breast Cancer Screening Products, Services and Solutions
Table 94. Revenue (US$ Million) in Computer-aided Detection (CAD) for Breast Cancer Screening Business of Siemens Healthineers AG (2019-2024)
Table 95. Siemens Healthineers AG Recent Developments
Table 96. Key Raw Materials Lists
Table 97. Raw Materials Key Suppliers Lists
Table 98. Computer-aided Detection (CAD) for Breast Cancer Screening Downstream Customers
Table 99. Computer-aided Detection (CAD) for Breast Cancer Screening Distributors List
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Computer-aided Detection (CAD) for Breast Cancer Screening Product Picture
Figure 2. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)
Figure 4. Computer-aided Detection (CAD) for Breast Cancer Screening Report Years Considered
Figure 5. Global Computer-aided Detection (CAD) for Breast Cancer Screening Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Computer-aided Detection (CAD) for Breast Cancer Screening Revenue in 2023
Figure 7. Computer-aided Detection (CAD) for Breast Cancer Screening Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Mammography CAD Picture
Figure 9. MRI CAD Picture
Figure 10. PET/CT CAD Picture
Figure 11. Ultrasound CAD Picture
Figure 12. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 13. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value Market Share by Type, 2023 & 2030
Figure 14. Product Picture of Clinics
Figure 15. Product Picture of Hospital
Figure 16. Product Picture of Medical Examination Center
Figure 17. Product Picture of Others
Figure 18. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 19. Global Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value Market Share by Application, 2023 & 2030
Figure 20. North America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)
Figure 21. North America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
Figure 22. Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)
Figure 23. Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
Figure 24. Asia Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)
Figure 25. Asia Pacific Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
Figure 26. South America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)
Figure 27. South America Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
Figure 28. Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value (2019-2030) & (US$ Million)
Figure 29. Middle East & Africa Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Country (%), 2023 VS 2030
Figure 30. Key Countries/Regions Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value (%), (2019-2030)
Figure 31. United States Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)
Figure 32. United States Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
Figure 33. United States Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030
Figure 34. Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)
Figure 35. Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
Figure 36. Europe Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030
Figure 37. China Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)
Figure 38. China Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
Figure 39. China Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030
Figure 40. Japan Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)
Figure 41. Japan Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
Figure 42. Japan Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030
Figure 43. South Korea Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)
Figure 44. South Korea Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
Figure 45. South Korea Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030
Figure 46. Southeast Asia Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)
Figure 47. Southeast Asia Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
Figure 48. Southeast Asia Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030
Figure 49. India Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value, (2019-2030) & (US$ Million)
Figure 50. India Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Type (%), 2023 VS 2030
Figure 51. India Computer-aided Detection (CAD) for Breast Cancer Screening Sales Value by Application (%), 2023 VS 2030
Figure 52. Computer-aided Detection (CAD) for Breast Cancer Screening Industrial Chain
Figure 53. Computer-aided Detection (CAD) for Breast Cancer Screening Manufacturing Cost Structure
Figure 54. Channels of Distribution (Direct Sales, and Distribution)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
